Illumina and Illumina Accelerator Partnering Day

Event Information

Share this event

Date and Time

Location

Location

The Office Group at Oxford Circus

2 Riding House St.

Marylebone

London

W1W 7FA

United Kingdom

View Map

Event description
Breakfast forum and 1:1 partnering opportunities with the Illumina Accelerator Team and hosted by LSX Ltd.

About this Event

Illumina is interested in:

  • Technologies related to genomics and their applications in agriculture, biotech, and health care
  • Applications of genomics including therapeutics, agriculture technologies, oncology, reproductive health, synthetic biology, direct to consumer, and diagnostics.
  • Bioinformatics and data analytics approaches.

Please note this breakfast and partnering day is specifically for CxOs of appropriate companies and executives from Academic Tech Transfer and Commercialisation offices only. Other profiles will be subject to review and may be cancelled.

The day is being hosted by LSX Ltd.

8:00am - Breakfast forum

8:00 am - Breakfast Buffet (coffee, pasties, fruit)

8:30 am - LSX Ltd. / Emcee Welcome

8:40 am - ILMN Overview

9:00 am - ILMN Accelerator Overview

9:20 am - Fireside chat with Accelerator entrepreneur - BioAmp Diagnostics

9:30 am - Forum wrap up & networking

10:00am - 1:1 partnering meetings

15-20 minute 1:1 private meetings with ILMN Accelerator team and ILMN BD

13:00pm - Close

Illumina Participants:

  • Amanda Cashin, Global Head Illumina Accelerator
  • Bobby Kaura, Head of Personalized Healthcare in Genomics, EMEA
  • Julie Moore, Director Business Development, EMEA
  • Gerald Kreindl, Senior Staff Program Manager, Scientific Research, Illumina, Inc.

A global genomics leader, Illumina provides complete next-generation sequencing workflow solutions to the basic and translational research communities. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.

Through collaborative innovation, Illumina fueling groundbreaking advancements in the fields of oncology, reproductive health, genetic disease, microbiology, agriculture, and forensic science.

In Summer 2019, Illumina announced the launch of Illumina Accelerator Cambridge, its first international expansion since the inception of Illumina Accelerator San Francisco Bay Area in 2014. Illumina Accelerator is a company creation engine focused on partnering with entrepreneurs to build break through genomics startups. The inaugural funding cycle of Illumina Accelerator Cambridge will begin in Spring 2020.

Applications for Illumina Accelerator’s inaugural funding cycle in Cambridge, UK and the eleventh funding cycle in the San Francisco Bay Area are due by November 1, 2019. Through a single, global application process, Illumina Accelerator will select up to five companies in each location to participate in two, six-month cycles per year. To learn more and apply, please visit www.illumina.com/accelerator.

Illumina is seeking to meet with research institutions, companies, and entrepreneurs at all stages to explore strategic partnerships, investments, and partnering opportunities. Additionally, Illumina Accelerator is interested in meeting with startups developing breakthrough applications in genomics.

About Illumina Accelerator

Illumina Accelerator is the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. It provides select startups with access to seed investment, business guidance, Illumina’s sequencing systems and reagents, and fully operational lab space in the San Francisco Bay Area or Cambridge, UK during each six-month funding cycle. Since launching in 2014, Illumina Accelerator has invested in 33 genomics startups from across the globe, which have collectively raised over $300 million in venture capital funding. For more information, visit www.illumina.com/accelerator and follow www.linkedin.com/company/illumina-accelerator

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

About LSX Ltd.

LSX is an influential community of senior life science decision makers. We connect senior life science executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses. We achieve this through a programme of high-level conferences and networking events, via content that showcases and shares the expertise of investors, senior leaders and industry stakeholders, as well as through bespoke initiatives. Visit us at www.lsxleaders.com

Date and Time

Location

The Office Group at Oxford Circus

2 Riding House St.

Marylebone

London

W1W 7FA

United Kingdom

View Map

Save This Event

Event Saved